tolbutamide has been researched along with Arteriosclerosis Obliterans in 4 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FEARNLEY, GR | 2 |
| CHAKRABARTI, R | 2 |
| Mayrhofer, E | 1 |
| Klieber, M | 1 |
| Thiele, P | 1 |
| Hocking, ED | 1 |
| Evans, J | 1 |
4 other studies available for tolbutamide and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
THE PHARMACOLOGICAL ENHANCEMENT OF BLOOD FIBRINOLYTIC ACTIVITY WITH SPECIAL REFERENCE TO PHENFORMIN.
Topics: Anabolic Agents; Anticoagulants; Arteriosclerosis Obliterans; Chlorpropamide; Coronary Disease; Fibr | 1964 |
[Incidence of diabetes in patients with arteriosclerotic occlusive disease of the legs].
Topics: Administration, Oral; Aged; Arteriosclerosis Obliterans; Body Weight; Cortisone; Diabetic Angiopathi | 1972 |
[Hyperlipemia--an accelerating factor in occlusive arterial diseases].
Topics: Arteriosclerosis Obliterans; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus; Fatty Acids | 1971 |
Fibrinolytic effect of biguanides.
Topics: Adult; Aged; Angina Pectoris; Arteriosclerosis Obliterans; Biguanides; Chlorpropamide; Coronary Dise | 1968 |